The FEDRA Longitudinal Study: Repeated Volumetric Breast Density Measures and Breast Cancer Risk.

breast cancer risk digital mammograms longitudinal study repeated measures volumetric mammographic breast density

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
16 Mar 2023
Historique:
received: 15 12 2022
revised: 14 03 2023
accepted: 15 03 2023
medline: 30 3 2023
entrez: 29 3 2023
pubmed: 30 3 2023
Statut: epublish

Résumé

Mammographic breast density (MBD) is a strong independent risk factor for breast cancer (BC). We investigated the association between volumetric MBD measures, their changes over time, and BC risk in a cohort of women participating in the FEDRA (Florence-EPIC Digital mammographic density and breast cancer Risk Assessment) study. The study was carried out among 6148 women with repeated MBD measures from full-field digital mammograms and repeated information on lifestyle habits, reproductive history, and anthropometry. The association between MBD measures (modeled as time-dependent covariates), their relative annual changes, and BC risk were evaluated by adjusted Cox models. During an average of 7.8 years of follow-up, 262 BC cases were identified. BC risk was directly associated with standard deviation increments of volumetric percent density (VPD, HR 1.37, 95%CI 1.22-1.54) and dense volume (DV, HR 1.29, 95%CI 1.18-1.41). An inverse association emerged with non-dense volume (NDV, HR 0.82, 95%CI 0.69-0.98). No significant associations emerged between annual changes in VPD, DV, NDV, and BC risk. Higher values of MBD measures, modeled as time-dependent covariates, were positively associated with increased BC risk, while an inverse association was evident for increasing NDV. No effect of annual changes in MBD emerged.

Identifiants

pubmed: 36980696
pii: cancers15061810
doi: 10.3390/cancers15061810
pmc: PMC10046534
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Italian Ministry of Health
ID : RF-2016-02364745
Organisme : Italian Association for Cancer Research
ID : 23702

Références

Int J Cancer. 2006 Apr 1;118(7):1782-9
pubmed: 16231317
Int J Cancer. 2009 Apr 1;124(7):1654-61
pubmed: 19085933
PLoS One. 2009;4(4):e5339
pubmed: 19396357
Cancer Epidemiol Biomarkers Prev. 2010 Dec;19(12):3096-105
pubmed: 20921336
Acta Radiol. 2018 May;59(5):527-532
pubmed: 28766978
Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):2877-80
pubmed: 16365004
Breast Cancer Res Treat. 2012 Feb;131(3):993-1002
pubmed: 21993860
Br J Cancer. 2000 Jul;83(1):121-6
pubmed: 10883679
Breast Cancer Res. 2018 Feb 05;20(1):10
pubmed: 29402289
Eur J Cancer. 2021 Nov;157:308-347
pubmed: 34560371
Breast Cancer Res Treat. 2009 Oct;117(3):643-51
pubmed: 19184416
J Natl Cancer Inst. 2020 Apr 1;112(4):391-399
pubmed: 31298705
Am J Epidemiol. 2013 Jul 1;178(1):101-9
pubmed: 23703889
Breast Cancer Res Treat. 2014 Apr;144(3):479-502
pubmed: 24615497
Lancet Oncol. 2005 Oct;6(10):798-808
pubmed: 16198986
Breast Cancer Res Treat. 2017 Jul;164(2):467-473
pubmed: 28478611
Breast Cancer Res Treat. 2008 Nov;112(1):165-74
pubmed: 18066689
Breast Cancer Res Treat. 2012 Sep;135(2):367-80
pubmed: 22814722
Breast Cancer Res. 2014 Sep 20;16(5):439
pubmed: 25239205
Cancer Epidemiol Biomarkers Prev. 2016 Jan;25(1):212-6
pubmed: 26545407
Tumori. 2003 Nov-Dec;89(6):586-93
pubmed: 14870823
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Int J Cancer. 2016 May 15;138(10):2346-56
pubmed: 26684063
Breast Cancer Res. 2007;9(5):R72
pubmed: 17949495
Maturitas. 2011 May;69(1):74-80
pubmed: 21377300
Int J Cancer. 2014 Oct 1;135(7):1740-4
pubmed: 24599445
Eur J Cancer Prev. 2017 Nov;26(6):511-520
pubmed: 27571214
Breast Cancer Res. 2013 Jan 04;15(1):R1
pubmed: 23289950
Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1159-69
pubmed: 16775176
Breast Cancer Res Treat. 2011 Aug;129(1):135-47
pubmed: 21373874
Eur J Cancer Prev. 1999 Dec;8(6):509-15
pubmed: 10643940
Cancer Epidemiol Biomarkers Prev. 2007 May;16(5):921-8
pubmed: 17507617
PLoS One. 2013 Aug 07;8(8):e70943
pubmed: 23951047
J Natl Cancer Inst. 2004 Apr 21;96(8):621-8
pubmed: 15100340
PLoS One. 2015 Sep 03;10(9):e0136667
pubmed: 26335569
JAMA. 2001 Jan 10;285(2):171-6
pubmed: 11176809

Auteurs

Giovanna Masala (G)

Clinical Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), 50139 Florence, Italy.

Melania Assedi (M)

Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), 50139 Florence, Italy.

Benedetta Bendinelli (B)

Clinical Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), 50139 Florence, Italy.

Elisa Pastore (E)

Clinical Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), 50139 Florence, Italy.

Maria Antonietta Gilio (MA)

Breast Cancer Screening Branch, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), 50139 Florence, Italy.

Vincenzo Mazzalupo (V)

Breast Cancer Screening Branch, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), 50139 Florence, Italy.

Andrea Querci (A)

Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), 50139 Florence, Italy.

Miriam Fontana (M)

Clinical Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), 50139 Florence, Italy.

Giacomo Duroni (G)

Clinical Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), 50139 Florence, Italy.

Luigi Facchini (L)

Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), 50139 Florence, Italy.

Calogero Saieva (C)

Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), 50139 Florence, Italy.

Domenico Palli (D)

Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), 50139 Florence, Italy.

Daniela Ambrogetti (D)

Breast Cancer Screening Branch, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), 50139 Florence, Italy.

Saverio Caini (S)

Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), 50139 Florence, Italy.

Classifications MeSH